Cedars-Sinai has one of the largest state-of-the-art clinical research trial facilities of any private hospital in the nation. Almost 600 clinical research projects—covering the entire spectrum of disease investigation—are actively underway to advance patient care and improve patient outcomes. Clinical trials are a crucial process in the discovery and testing of new drugs, new ways of giving patients approved drugs, new combinations of approved drugs, surgical techniques, devices and biological products. Patient participation is a centerpiece to this entire body of work.
Cedars-Sinai is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for all research involving the protection of patients. AAHRPP is a Washington, DC, based non-profit organization that uses a voluntary, peer-driven, educational model to accredit institutions engaged in research involving human subjects.
Search for Clinical Trials and Studies
Clinical Trial Areas
Cedars-Sinai is committed to applying research discovery for improving patient care. The Burns and Allen Research Institute provides a strong scientific, clinical and administration infrastructure to support investigations across a wide range of healthcare programs.
These are a few areas where clinical trials are actively underway.
Clinical Trial Awareness
One in every three women and one in every two men can expect a cancer diagnosis in their lifetime. All the major advances in cancer and all the best cancer treatments available today are because of clinical trials. Learn more about what has attracted hundreds of thousands of patients to participate in cancer clinical trials.
Preparing graduates for a successful career in emerging healthcare fields, including digital health science, mobile health, big data analytics and performance improvement.
Cedars-Sinai supports its research scientists and health practitioners with programs, services, technologies, facilities and other resources for accelerating advanced clinical research projects, enabling access to leading-edge therapies and medical technologies in clinical trials.